AT356264B - Verfahren zur herstellung eines trockenen anti- biotischen medikaments - Google Patents

Verfahren zur herstellung eines trockenen anti- biotischen medikaments

Info

Publication number
AT356264B
AT356264B AT128475A AT128475A AT356264B AT 356264 B AT356264 B AT 356264B AT 128475 A AT128475 A AT 128475A AT 128475 A AT128475 A AT 128475A AT 356264 B AT356264 B AT 356264B
Authority
AT
Austria
Prior art keywords
biotic
medicine
producing
dry anti
dry
Prior art date
Application number
AT128475A
Other languages
English (en)
Other versions
ATA128475A (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23765656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT356264(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ATA128475A publication Critical patent/ATA128475A/de
Application granted granted Critical
Publication of AT356264B publication Critical patent/AT356264B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
AT128475A 1974-02-22 1975-02-20 Verfahren zur herstellung eines trockenen anti- biotischen medikaments AT356264B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US444622A US3928592A (en) 1974-02-22 1974-02-22 Antibiotic pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ATA128475A ATA128475A (de) 1979-09-15
AT356264B true AT356264B (de) 1980-04-25

Family

ID=23765656

Family Applications (1)

Application Number Title Priority Date Filing Date
AT128475A AT356264B (de) 1974-02-22 1975-02-20 Verfahren zur herstellung eines trockenen anti- biotischen medikaments

Country Status (24)

Country Link
US (1) US3928592A (de)
JP (1) JPS6119605B2 (de)
AR (1) AR203895A1 (de)
AT (1) AT356264B (de)
BE (1) BE825653A (de)
CA (1) CA1043261A (de)
CH (1) CH620929A5 (de)
CS (1) CS189689B2 (de)
DD (1) DD117807A5 (de)
DE (1) DE2506622A1 (de)
DK (1) DK153919C (de)
ES (1) ES434976A1 (de)
FR (1) FR2261772B1 (de)
GB (1) GB1493676A (de)
HU (1) HU174129B (de)
IE (1) IE40671B1 (de)
IL (1) IL46650A (de)
NL (1) NL179976C (de)
PH (1) PH12058A (de)
PL (1) PL109311B1 (de)
SE (1) SE406153B (de)
SU (1) SU659094A3 (de)
YU (1) YU41875A (de)
ZA (1) ZA75975B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054738A (en) * 1975-12-22 1977-10-18 Eli Lilly And Company Sodium cefamandole crystalline forms
JPS5283956A (en) * 1976-01-01 1977-07-13 Lilly Co Eli Antibiotic method and medical composition
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
JPS5711909A (en) * 1980-06-23 1982-01-21 Shionogi & Co Ltd Stable freeze-dried preparation of beta-lactam
IL93618A0 (en) * 1989-03-06 1990-12-23 Lilly Co Eli Improved diluent formulation for daptomycin
JP4873207B2 (ja) * 2001-02-26 2012-02-08 東レ・ファインケミカル株式会社 光学活性カルボン酸クロリドの精製方法
CN101880290B (zh) * 2010-06-28 2012-03-07 海南新中正制药有限公司 头孢孟多酯钠的制备方法
WO2013057196A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
WO2013057197A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the formylation of cefamandole
US9834567B1 (en) * 2014-12-16 2017-12-05 Tianjin University Crystalline form of cefamandole nafate compound, preparation and preparing method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767891C3 (de) * 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
SE406153B (sv) 1979-01-29
ZA75975B (en) 1976-09-29
AU7833975A (en) 1976-08-19
DK65575A (de) 1975-10-20
DK153919C (da) 1989-02-06
YU41875A (en) 1982-05-31
ES434976A1 (es) 1976-12-16
BE825653A (fr) 1975-08-18
CS189689B2 (en) 1979-04-30
PH12058A (en) 1978-10-18
DE2506622A1 (de) 1975-08-28
CH620929A5 (de) 1980-12-31
HU174129B (hu) 1979-11-28
SE7501985L (de) 1975-08-23
ATA128475A (de) 1979-09-15
CA1043261A (en) 1978-11-28
IE40671B1 (en) 1979-07-18
NL7502045A (nl) 1975-08-26
JPS6119605B2 (de) 1986-05-17
NL179976C (nl) 1986-12-16
IE40671L (en) 1975-08-22
US3928592A (en) 1975-12-23
PL109311B1 (en) 1980-05-31
FR2261772A1 (de) 1975-09-19
NL179976B (nl) 1986-07-16
GB1493676A (en) 1977-11-30
AR203895A1 (es) 1975-10-31
DK153919B (da) 1988-09-26
IL46650A (en) 1977-10-31
DE2506622C2 (de) 1987-02-26
FR2261772B1 (de) 1980-01-04
SU659094A3 (ru) 1979-04-25
DD117807A5 (de) 1976-02-05
IL46650A0 (en) 1975-05-22
JPS50126817A (de) 1975-10-06

Similar Documents

Publication Publication Date Title
AT347038B (de) Verfahren zur herstellung eines diaetpraeparats
AT349864B (de) Verfahren zur herstellung eines neuen nahrungsmittels
DE2551961A1 (de) Verfahren zur herstellung eines halbleiterbauelementes
AT339051B (de) Verfahren zur herstellung eines anorganisch-organischen kunststoffes
AT341083B (de) Verfahren zur herstellung neuer rifamycine
AT356264B (de) Verfahren zur herstellung eines trockenen anti- biotischen medikaments
AT344865B (de) Verfahren zur herstellung eines effektgarns
AT338968B (de) Verfahren zur herstellung eines arzneimittels
ATA939874A (de) Bindepechs eines verfahren zur herstellung
AT341774B (de) Verfahren zur herstellung eines copolymerisationsproduktes
AT347050B (de) Verfahren zur herstellung eines neuen 6-mehtyl- 8beta- (substituierten)-methylergolins
ATA986075A (de) Verfahren zur herstellung neuer indolderivate
AT348520B (de) Verfahren zur herstellung eines neuen tetrazolderivats
AT343250B (de) Verfahren zur herstellung eines detergens
DD129783A5 (de) Verfahren zur herstellung eines enons
AT335485B (de) Verfahren zur herstellung eines harnstoff-formaldehyd-dungers
ATA924875A (de) Verfahren zur herstellung neuer 5-nitroimida- zolderivate
AT356055B (de) Verfahren zur herstellung eines schussfaden- losen bandes
AT338514B (de) Verfahren zur herstellung eines katalysators
AT340588B (de) Verfahren zur herstellung eines neuen antibiotikumderivates
CH513641A (de) Verfahren zur Herstellung eines Zahnersatzes
AT338513B (de) Verfahren zur herstellung eines katalysators
AT344162B (de) Verfahren zur herstellung neuer benzisoxazol-derivate
ATA602975A (de) Verfahren zur herstellung eines neuen abtibiotikums
AT339476B (de) Verfahren zur herstellung eines neuen antibiotikakomplexes

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
REN Ceased due to non-payment of the annual fee